Trademark: 87725262
Status Date
Monday, August 16, 2021
Filing Date
Monday, December 18, 2017
Published for Opposition
Tuesday, May 15, 2018
Abandoned Date
Monday, August 16, 2021
5 Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical products; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases and disorders; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and disorders; pharmaceutical preparations for the prevention and treatment of endocrinological diseases and disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases or disorders; pharmaceutical preparations for the prevention and treatment of liver diseases or disorders pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in gynecology and urology; pharmaceutical products for ophthalmological use; pharmaceutical products for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical products for the prevention and treatment of bone diseases; pharmaceutical products for the prevention and treatment of genetic diseases and disorders
Aug 16, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 16, 2021
Abandonment - No Use Statement Filed
Dec 31, 2020
Notice Of Approval Of Extension Request E-Mailed
Dec 30, 2020
Extension 5 Granted
Dec 11, 2020
Extension 5 Filed
Dec 30, 2020
Case Assigned To Intent To Use Paralegal
Dec 11, 2020
Teas Extension Received
Jul 2, 2020
Notice Of Approval Of Extension Request E-Mailed
Jun 30, 2020
Extension 4 Granted
Jun 30, 2020
Extension 4 Filed
Jun 30, 2020
Teas Extension Received
Jan 7, 2020
Notice Of Approval Of Extension Request E-Mailed
Jan 3, 2020
Extension 3 Granted
Jan 3, 2020
Extension 3 Filed
Jan 3, 2020
Teas Extension Received
Oct 11, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 11, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 10, 2019
Notice Of Approval Of Extension Request E-Mailed
Jul 8, 2019
Extension 2 Granted
Jul 8, 2019
Extension 2 Filed
Jul 8, 2019
Teas Extension Received
Jan 8, 2019
Notice Of Approval Of Extension Request E-Mailed
Jan 4, 2019
Extension 1 Granted
Jan 4, 2019
Extension 1 Filed
Jan 4, 2019
Teas Extension Received
Jul 10, 2018
Noa E-Mailed - Sou Required From Applicant
May 15, 2018
Official Gazette Publication Confirmation E-Mailed
May 15, 2018
Published For Opposition
Apr 25, 2018
Notification Of Notice Of Publication E-Mailed
Apr 4, 2018
Assigned To Lie
Mar 30, 2018
Approved For Pub - Principal Register
Mar 30, 2018
Examiner's Amendment Entered
Mar 30, 2018
Notification Of Examiners Amendment E-Mailed
Mar 30, 2018
Examiners Amendment E-Mailed
Mar 30, 2018
Examiners Amendment -Written
Mar 27, 2018
Assigned To Examiner
Jan 4, 2018
New Application Office Supplied Data Entered In Tram
Dec 21, 2017
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
